Dr Graham Murray

University position

Associate Professor

Dr Graham Murray is pleased to consider applications from prospective PhD students.


Department of Psychiatry


Behavioural and Clinical Neuroscience Institute



Home page


Research Themes

Clinical and Veterinary Neuroscience

Cognitive and Behavioural Neuroscience


I work on the causes, brain mechanisms and treatments of mental disorder. I utilize a variety of neuroscience techniques, including statistical genomics, brain imaging, computational psychiatry, pharmacological and neuropsychological studies in patients and healthy volunteers. I study cognitive developmental epidemiology, the relationship between cognitive development and mental illness across the lifespan, and on the mechanisms through which etiological factors (such as genetics) lead to pathophysiological disruptions in mental illness. I also research the role of surprise (prediction error) when people learn from experience in uncertain conditions, and how expectation shapes experience (predictive processing). I study transdiagnostic mechanisms of symptoms such as delusions, hallucinations and anhedonia, and am interested in the research and clinical applications of polygenic risk scores.

Research Focus






Prediction error

Clinical conditions

Bipolar disorder

Depressive disorders

Early psychosis

Parkinson's disease

Populations at high clinical risk for psychosis



Behavioural analysis

Computational modelling


Magnetic resonance imaging (MRI)

Mendelian randomisation

Neuropsychological testing

Randomised control trials



Richard Bethlehem

Paul Fletcher

Jane Garrison

Peter Jones

Pietro Lio'

Trevor Robbins

Chris Rodgers

John Suckling

Petra Vertes

Varun Warrior

United Kingdom

Peter Kok

Michael Moutoussis

Daniel Smith


Erika Jääskeläinen

John McGrath

Jouko Miettunen

Tomas Paus Web: https://research.hollandbloorview.ca/scienti...

Juha Veijola Web: http://kelo.oulu.fi/NFBC/

Naomi Wray Web: http://cnsgenomics.com

Associated News Items

Key publications

Haarsma, J., Fletcher, P. C., Griffin, J. D., Taverne, H. J., Ziauddeen, H., Spencer, T. J., Miller, C., Katthagen, T., Goodyer, I., Diederen, K., & Murray, G. K. (2020), “Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis. ” Molecular Psychiatry https://doi.org/10.1038/s41380-020-0803-8

Murray GK, Lin T, Austin J, McGrath JJ, Hickie IB, Wray NR (2020), “Polygenic Risk Scores - could they be useful in psychiatry?” JAMA psychiatry 2020 Oct 14. doi: 10.1001/jamapsychiatry.2020.3042.

Rollins CPE, Garrison JR, Arribas M, Seyedsalehi A, Li Z, Chan RCK, Yang J, Wang D, Liò P, Yan C, Yi ZH, Cachia A, Upthegrove R, Deakin B, Simons JS, Murray GK*, Suckling J*. (2020), “Evidence in cortical folding patterns for prenatal predispositions to hallucinations in schizophrenia. ” Translational Psychiatry Nov 6;10(1):387. doi: 10.1038/s41398-020-01075-y.

Tripoli G, ... EU-GEI WP2 Group, Murray GK & Di Forti M (2020), “Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentre EU-GEI Case-Control Study” Psychological Medicine https://doi.org/10.1017/S003329171900357X

Wray NR, Lin T, Austin J, McGrath JJ, Hickie IB, Murray GK, Visscher PM (2020), “Polygenic risk scores - a primer for clinicians” JAMA Psychiatry 2021 Jan 1;78(1):101-109.

Veijola J, Guo JY, Moilanen JS, Jääskeläinen E, Miettunen J, Kyllönen M, Haapea M, Huhtaniska S, Alaräisänen A, Mäki P, Kiviniemi V, Nikkinen J, Starck T, Remes JJ, Tanskanen P, Tervonen O, Wink AM, Kehagia A, Suckling J, Kobayashi H, Barnett JH, Barnes A, Koponen HJ, Jones PB, Isohanni M, Murray GK (2014), “Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.” PLoS One 9(7):e101689 Details

Murray GK, Jones PB (2012), “Psychotic symptoms in young people without psychotic illness: mechanisms and meaning.” Br J Psychiatry 201(1):4-6 Details

Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, Bullmore ET, Jones PB (2008), “Reinforcement and reversal learning in first-episode psychosis.” Schizophr Bull 34(5):848-55 Details

Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, Bullmore ET, Robbins TW, Fletcher PC (2008), “Substantia nigra/ventral tegmental reward prediction error disruption in psychosis.” Mol Psychiatry 13(3):239, 267-76 Details



Yeda Wu, Graham K Murray, Enda M Byrne, Julia Sidorenko, Peter M Visscher, Naomi R. Wray. (2021), “GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression.” Nature Communications 12, 1146 (2021). https://doi.org/10.1038/s41467-021-21280-7


Anna O Ermakova, Nimrod Gileadi, Franziska Knolle, Azucena Justicia Diaz, Rachel Anderson, Paul C Fletcher, Michael Moutoussis, Graham Murray. (2020), “Cost evaluation during decision making in patients at early stages of psychosis” Computational Psychiatry 2019 volume 3 p18-39 www.mitpressjournals.org/doi/10.1162/cpsy_a_00020

Haarsma J, Knolle F, Griffin JD, Taverne H, Mada M, Goodyer IM, The Nspn Consortium, Fletcher PC, Murray GK. (2020), “Influence of prior beliefs on perception in early psychosis: Effects of illness stage and hierarchical level of belief. ” J Abnorm Psychol. Aug;129(6):581-598. doi: 10.1037/abn0000494.

Knolle, F., Garofalo, S., Viviani, R., Justicia, A., Ermakova, A. O., Blank, H., Williams, G. B., Arrondo, G., Ramachandra, P., Tudor-Sfetea, C., Bunzeck, N., Duezel, E., Robbins, T. W., Barker, R. A., & Murray, G. K. (2020), “Altered subcortical emotional salience processing differentiates Parkinson's patients with and without psychotic symptoms.” NeuroImage. Clinical, 27, 102277. Advance online publication. https://doi.org/10.1016/j.nicl.2020.102277

Montagnese, M., Knolle, F., Haarsma, J., Griffin, J. D., Richards, A., Vertes, P. E., Kiddle, B., Fletcher, P. C., Jones, P. B., Owen, M. J., Fonagy, P., Bullmore, E. T., Dolan, R. J., NSPN Consortium, Moutoussis, M., Goodyer, I. M., & Murray, G. K. (2020), “Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population. ” Schizophrenia Research https://doi.org/10.1016/j.schres.2020.04.022


Michielse S, Lange I, Bakker J, Goossens L, Verhagen S, Papalini S, Wichers M, Lieverse R, Schruers K, van Amelsvoort T , Jim van Os , Graham K Murray*, Machteld Marcelis* (2019), “Reward Anticipation in individuals with Subclinical Psychotic Experiences: A Functional MRI Approach. ” European Neuropsychopharmacology. Volume 29, Issue 12, December 2019, Pages 1374-1385 .Volume 29, Issue 12, December 2019, Pages 1374-1385

Ward, J., Lyall, L. M., Bethlehem, R., Ferguson, A., Strawbridge, R. J., Lyall, D. M., Cullen, B., Graham, N., Johnston, K., Bailey, M., Murray, G. K., & Smith, D. J. (2019), “Novel genome-wide associations for anhedonia, genetic correlation with psychiatric disorders, and polygenic association with brain structure. ” Translational Psychiatry https://doi.org/10.1038/s41398-019-0635-y


Anna O. Ermakova, Franziska Knolle, Azucena Justicia, Edward T. Bullmore, Peter B. Jones, Trevor W. Robbins, Paul C. Fletcher, Graham K. Murray (2018), “Abnormal reward prediction error signalling in antipsychotic naive individuals with first episode psychosis or clinical risk for psychosis” Neuropsychopharmacology. 2018 Apr 5. doi: 10.1038/s41386-018-0056-2

Franziska Knolle, Anna O Ermakova, Azucena Justicia, Paul C Fletcher, Nico Bunzeck, Emrah Duzel, Graham Murray (2018), “Altered cingulate and substantia nigra/ventral tegmental activation to novelty and emotional salience in antipsychotic naive first episode psychosis patients” Translational Psychiatry Sep 21;8(1):196. doi: 10.1038/s41398-018-0250-3

Heinz A, Murray GK, Schlagenhauf F, Sterzer P, Grace AA, Waltz JA. (2018), “Towards a Unifying Cognitive, Neurophysiological, and Computational Neuroscience Account of Schizophrenia.” Schizophrenia Bulletin doi: 10.1093/schbul/sby154

Lieslehto J, Kiviniemi VJ, Nordström T, Barnett JH, Murray GK, Jones PB, Paus T, Veijola J. (2018), “Polygenic Risk Score for Schizophrenia and Face-Processing Network in Young Adulthood” Schizophrenia Bulletin 10.1093/schbul/sby139

Mustonen A, Ahokas T, Nordström T, Murray GK, Mäki P, Jääskeläinen E, Heiskala A, Mcgrath JJ, Scott JG, Miettunen J, Niemelä S. (2018), “Smokin' hot: adolescent smoking and the risk of psychosis.” Acta Psychiatrica Scandinavica Jul;138(1):5-14. doi: 10.1111/acps.12863.

Mustonen A, Niemelä S, Nordström T, Murray GK, Mäki P, Jääskeläinen E, Miettunen J. (2018), “Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.” British Journal of Psychiatry Apr;212(4):227-233. doi: 10.1192/bjp.2017.52.

Osimo EF, Goujon MJ, Perez J, Murray GK. (2018), “Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia? ” BMJ Case Reports BMJ Case Rep. 2019 Mar 31;12(3). pii: e228573. doi: 10.1136/bcr-2018-228573.


Graham K Murray, Franziska Knolle, Karen D Ersche, Kevin J Craig, Sanja Abbot, Shalia S Shabbir, Naomi A Fineberg, John Suckling, Barbara J Sahakian, Edward T Bullmore, Trevor W Robbins (2017), “Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder” bioRxiv 225938; BioRxiv doi: https://doi.org/10.1101/225938

Huhtaniska S, Jääskeläinen E, Hirvonen N, Remes J, Murray GK, Veijola J, Isohanni M, Miettunen J (2017), “Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.” Hum Psychopharmacol

Husa AP, Moilanen J, Murray GK, Marttila R, Haapea M, Rannikko I, Barnett JH, Jones PB, Isohanni M, Remes AM, Koponen H, Miettunen J, Jääskeläinen E. (2017), “Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.” Psychiatry Res 247:130-138.

Metcalf SA, Jones PB, Nordstrom T, Timonen M, Mäki P, Miettunen J, Jääskeläinen E, Järvelin MR, Stochl J, Murray GK, Veijola J, Khandaker GM. (2017), “Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study. ” Brain Behav Immun. 59:253-259.


Guo JY, Isohanni M, Miettunen J, Jääskeläinen E, Kiviniemi V, Nikkinen J, Remes J, Huhtaniska S, Veijola J, Jones PB, Murray GK (2016), “ Brain structural changes in women and men during midlife.” Neurosci Lett. 26;615:107-12.

Rannikko I, Jääskeläinen E, Miettunen J, Ahmed AO, Veijola J, Remes AM, Murray GK, Husa AP, Järvelin MR, Isohanni M, Haapea M. (2016), “Predictors of Long-Term Change in Adult Cognitive Performance: Systematic Review and Data from the Northern Finland Birth Cohort 1966. ” Clin Neuropsychol. 2016;30(1):17-50. 30(1):17-50.

Roman-Urrestarazu A, Lindholm P, Moilanen I, Kiviniemi V, Miettunen J, Jääskeläinen E, Mäki P, Hurtig T, Ebeling H, Barnett JH, Nikkinen J, Suckling J, Jones PB, Veijola J, Murray GK. (2016), “Brain structural deficits and working memory fMRI dysfunction in young adults who were diagnosed with ADHD in adolescence. ” 2016 May;25(5):529-38 25(5):529-38

Segarra N, Metastasio A, Ziauddeen H, Spencer J, Reinders NR, Dudas RB, Arrondo G, Robbins TW, Clark L, Fletcher PC, Murray GK. (2016), “Abnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to Anhedonia.” Neuropsychopharm 41(8):2001-10


Arrondo G, Segarra N, Metastasio A, Ziauddeen H, Spencer J, Reinders NR, Dudas RB, Robbins TW, Fletcher PC, Murray GK. (2015), “Reduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding. ” Front Psychol. 26;6:1280.

Guo JY, Huhtaniska S, Miettunen J, Jääskeläinen E, Kiviniemi V, Nikkinen J, Moilanen J, Haapea M, Mäki P, Jones PB, Veijola J, Isohanni M, Murray GK. (2015), “ Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function. ” Schizophr Res. 68(1-2):297-304.

Hussain H, Murray GK (2015), “Common childhood neurodevelopmental disorders are associated with increased risk of psychotic experiences in early adolescence.” Evid Based Ment Health 18(2):51 Details

Jukuri T, Kiviniemi V, Nikkinen J, Miettunen J, Mäki P, Mukkala S, Koivukangas J, Nordström T, Parkkisenniemi J, Moilanen I, Barnett JH, Jones PB, Murray GK, Veijola J (2015), “Central executive network in young people with familial risk for psychosis--the Oulu Brain and Mind Study.” Schizophr Res 161(2-3):177-83 Details

Pulkkinen J, Nikkinen J, Kiviniemi V, Mäki P, Miettunen J, Koivukangas J, Mukkala S, Nordström T, Barnett JH, Jones PB, Moilanen I, Murray GK, Veijola J (2015), “Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study.” Schizophr Res 164(1-3):242-9 Details

Scoriels L, Salek RM, Goodby E, Grainger D, Dean AM, West JA, Griffin JL, Suckling J, Nathan PJ, Lennox BR, Murray GK, Bullmore ET, Jones PB (2015), “Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.” Transl Psychiatry 5:e540 Details


Chuang JY, Murray GK, Metastasio A, Segarra N, Tait R, Spencer J, Ziauddeen H, Dudas RB, Fletcher PC, Suckling J (2014), “Brain structural signatures of negative symptoms in depression and schizophrenia.” Front Psychiatry 5:116 Details

Ermakova AO, Ramachandra P, Corlett PR, Fletcher PC, Murray GK (2014), “Effects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humans.” PLoS One 9(7):e102683 Details

Husa AP, Rannikko I, Moilanen J, Haapea M, Murray GK, Barnett J, Jones PB, Isohanni M, Koponen H, Miettunen J, Jääskeläinen E (2014), “Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.” Schizophr Res Details

Kobayashi H, Isohanni M, Jääskeläinen E, Miettunen J, Veijola J, Haapea M, Järvelin MR, Jones PB, Murray GK (2014), “Linking the Developmental and Degenerative Theories of Schizophrenia: Association Between Infant Development and Adult Cognitive Decline.” Schizophr Bull Details

Mäki P, Koskela S, Murray GK, Nordström T, Miettunen J, Jääskeläinen E, Veijola JM (2014), “Difficulty in making contact with others and social withdrawal as early signs of psychosis in adolescents - the Northern Finland Birth Cohort 1986.” Eur Psychiatry Details

Roman-Urrestarazu A, Murray GK, Barnes A, Miettunen J, Jääskeläinen E, Mäki P, Nikkinen J, Remes J, Mukkala S, Koivukangas J, Heinimaa M, Moilanen I, Suckling J, Kiviniemi V, Jones PB, Veijola J (2014), “Brain structure in different psychosis risk groups in the Northern Finland 1986 Birth Cohort.” Schizophr Res Details


Bernacer J, Corlett PR, Ramachandra P, McFarlane B, Turner DC, Clark L, Robbins TW, Fletcher PC, Murray GK (2013), “Methamphetamine-Induced Disruption of Frontostriatal Reward Learning Signals: Relation to Psychotic Symptoms.” Am J Psychiatry Details

Jääskeläinen E, Juola P, Kurtti J, Haapea M, Kyllönen M, Miettunen J, Tanskanen P, Murray GK, Huhtaniska S, Barnes A, Veijola J, Isohanni M (2013), “Associations between brain morphology and outcome in schizophrenia in a general population sample.” Eur Psychiatry Details

Jukuri T, Kiviniemi V, Nikkinen J, Miettunen J, Mäki P, Jääskeläinen E, Mukkala S, Koivukangas J, Nordström T, Taanila A, Moilanen I, Heinimaa M, Barnett JH, Jones PB, Murray GK, Veijola J (2013), “Default mode network in young people with familial risk for psychosis - The Oulu Brain and Mind Study.” Schizophr Res 143(2-3):239-45 Details

Miettunen J, Murray GK, Jones PB, Mäki P, Ebeling H, Taanila A, Joukamaa M, Savolainen J, Törmänen S, Järvelin MR, Veijola J, Moilanen I (2013), “Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use.” Psychol Med :1-12 Details

Mukkala S, Ilonen T, Koskela J, Nordström T, Loukkola J, Miettunen J, Barnett JH, Murray GK, Jones PB, Heinimaa M, Jääskeläinen E, Mäki P, Moilanen I, Veijola J (2013), “Response initiation in young adults at risk for psychosis in the Northern Finland 1986 Birth Cohort.” Cogn Neuropsychiatry Details


Barnes A, Isohanni M, Barnett JH, Pietiläinen O, Veijola J, Miettunen J, Paunio T, Tanskanen P, Ridler K, Suckling J, Bullmore ET, Jones PB, Murray GK (2012), “Neuregulin-1 genotype is associated with structural differences in the normal human brain.” Neuroimage 59(3):2057-61 Details

Barnes A, Isohanni M, Barnett JH, Pietiläinen O, Veijola J, Miettunen J, Paunio T, Tanskanen P, Ridler K, Suckling J, Bullmore ET, Murray GK, Jones PB (2012), “No Association of COMT (Val158Met) Genotype with Brain Structure Differences between Men and Women.” PLoS One 7(3):e33964 Details

Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, Jones PB, Bentall RP, Lewis SW, Murray GK, Patterson P, Brunet K, Conroy J, Parker S, Reilly T, Byrne R, Davies LM, Dunn G (2012), “Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.” BMJ 344:e2233 Details

Rannikko I, Paavola L, Haapea M, Huhtaniska S, Miettunen J, Veijola J, Murray GK, Barnes A, Wahlberg KE, Isohanni M, Jääskeläinen E (2012), “Verbal learning and memory and their associations with brain morphology and illness course in schizophrenia spectrum psychoses.” J Clin Exp Neuropsychol Details

Veijola J, Mäki P, Jääskeläinen E, Koivukangas J, Moilanen I, Taanila A, Nordström T, Hurtig T, Kiviniemi V, Mukkala S, Heinimaa M, Lindholm P, Jones PB, Barnett JH, Murray GK, Miettunen J (2012), “Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study.” Early Interv Psychiatry Details


Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, Jones PB (2011), “Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.” Psychol Med 41(5):949-58 Details

Morrison AP, Stewart SL, French P, Bentall RP, Birchwood M, Byrne R, Davies LM, Fowler D, Gumley AI, Jones PB, Lewis SW, Murray GK, Patterson P, Dunn G (2011), “Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.” Early Interv Psychiatry 5(1):24-32 Details

Mukkala S, Ilonen T, Nordström T, Miettunen J, Loukkola J, Barnett JH, Murray GK, Jääskeläinen E, Mäki P, Taanila A, Moilanen I, Jones PB, Heinimaa M, Veijola J (2011), “Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort.” J Clin Exp Neuropsychol 33(4):385-94 Details

Murray GK (2011), “The emerging biology of delusions.” Psychol Med 41(1):7-13 Details

Scoriels L, Barnett JH, Murray GK, Cherukuru S, Fielding M, Cheng F, Lennox BR, Sahakian BJ, Jones PB (2011), “Effects of modafinil on emotional processing in first episode psychosis.” Biol Psychiatry 69(5):457-64 Details

Tanskanen P, Valkama M, Haapea M, Barnes A, Ridler K, Miettunen J, Murray GK, Veijola JM, Jones PB, Taanila AM, Isohanni MK (2011), “Is prematurity associated with adult cognitive outcome and brain structure?” Pediatr Neurol 44(1):12-20 Details


Holcomb HH, Murray GK (2010), “Successful learning in schizophrenia, functional neuroimaging studies, and theoretical considerations.” Schizophr Bull 36(3):463-4 Details

Kehagia AA, Murray GK, Robbins TW (2010), “Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation.” Curr Opin Neurobiol 20(2):199-204 Details

Mäki P, Riekki T, Miettunen J, Isohanni M, Jones PB, Murray GK, Veijola J (2010), “Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis.” Am J Psychiatry 167(1):70-7 Details

Murray GK, Corlett PR, Fletcher PC (2010), “The Neural Underpinnings of Associative Learning in Health and Psychosis: How Can Performance Be Preserved When Brain Responses Are Abnormal?” Schizophr Bull Details

Penttilä M, Jääskeläinen E, Haapea M, Tanskanen P, Veijola J, Ridler K, Murray GK, Barnes A, Jones PB, Isohanni M, Koponen H, Miettunen J (2010), “Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.” Schizophr Res Details

Pomarol-Clotet E, Salvador R, Murray G, Tandon S, McKenna PJ (2010), “Are there valid subtypes of schizophrenia? A grade of membership analysis.” Psychopathology 43(1):53-62 Details

Poustka L, Murray GK, Jääskeläinen E, Veijola J, Jones P, Isohanni M, Miettunen J (2010), “The influence of temperament on symptoms and functional outcome in people with psychosis in the Northern Finland 1966 Birth Cohort.” Eur Psychiatry 25(1):26-32 Details

Ziauddeen H, Murray GK (2010), “The relevance of reward pathways for schizophrenia.” Curr Opin Psychiatry 23(2):91-6 Details


Corlett PR, Simons JS, Pigott JS, Gardner JM, Murray GK, Krystal JH, Fletcher PC (2009), “Illusions and delusions: relating experimentally-induced false memories to anomalous experiences and ideas.” Front Behav Neurosci 3:53 Details

Lebreton M, Barnes A, Miettunen J, Peltonen L, Ridler K, Veijola J, Tanskanen P, Suckling J, Jarvelin MR, Jones PB, Isohanni M, Bullmore ET, Murray GK (2009), “The brain structural disposition to social interaction.” Eur J Neurosci 29(11):2247-52 Details

Murray G (2009), “Dopamine dysfunction and delusions, hallucinations and anhedonia” European Psychiatric Review 2(1): 21-23


Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Bullmore ET, Menon DK, Fletcher PC (2008), “Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.” J Neurosci 28(25):6295-303 Details

Jääskeläinen E, Miettunen J, Veijola J, McGrath JJ, Murray GK, Jones PB, Isohanni M (2008), “Associations between early development and outcome in schizophrenia--A 35-year follow-up of the Northern Finland 1966 Birth Cohort.” Schizophr Res 99(1-3):29-37 Details

Miettunen J, Törmänen S, Murray GK, Jones PB, Mäki P, Ebeling H, Moilanen I, Taanila A, Heinimaa M, Joukamaa M, Veijola J (2008), “Association of cannabis use with prodromal symptoms of psychosis in adolescence.” Br J Psychiatry 192:470-1 Details

Murray GK, Clark L, Corlett PR, Blackwell AD, Cools R, Jones PB, Robbins TW, Poustka L (2008), “Incentive motivation in first-episode psychosis: a behavioural study.” BMC Psychiatry 8:34 Details

Tanskanen P, Ridler K, Murray GK, Haapea M, Veijola JM, Jääskeläinen E, Miettunen J, Jones PB, Bullmore ET, Isohanni MK (2008), “Morphometric Brain Abnormalities in Schizophrenia in a Population-Based Sample: Relationship to Duration of Illness.” Schizophr Bull Details


Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB (2007), “Substance use in a population-based clinic sample of people with first-episode psychosis.” Br J Psychiatry 190:515-20 Details

Corlett PR, Murray GK, Honey GD, Aitken MR, Shanks DR, Robbins TW, Bullmore ET, Dickinson A, Fletcher PC (2007), “Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions.” Brain 130(Pt 9):2387-400 Details

Murray GK, Jones PB, Kuh D, Richards M (2007), “Infant developmental milestones and subsequent cognitive function.” Ann Neurol 62(2):128-36 Details


Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Robbins TW, Bullmore ET, Fletcher PC (2006), “Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.” Arch Gen Psychiatry 63(6):611-21 Details

Isohanni M, Miettunen J, Mäki P, Murray GK, Ridler K, Lauronen E, Moilanen K, Alaräisänen A, Haapea M, Isohanni I, Ivleva E, Tamminga C, McGrath J, Koponen H (2006), “Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study.” World Psychiatry 5(3):168-71 Details

Murray GK, Jones PB, Moilanen K, Veijola J, Miettunen J, Cannon TD, Isohanni M (2006), “Infant motor development and adult cognitive functions in schizophrenia.” Schizophr Res 81(1):65-74 Details

Murray GK, Veijola J, Moilanen K, Miettunen J, Glahn DC, Cannon TD, Jones PB, Isohanni M (2006), “Infant motor development is associated with adult cognitive categorisation in a longitudinal birth cohort study.” J Child Psychol Psychiatry 47(1):25-9 Details

Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, McKenna PJ, Bullmore ET, Fletcher PC (2006), “Psychological effects of ketamine in healthy volunteers. Phenomenological study.” Br J Psychiatry 189:173-9 Details

Ridler K, Veijola JM, Tanskanen P, Miettunen J, Chitnis X, Suckling J, Murray GK, Haapea M, Jones PB, Isohanni MK, Bullmore ET (2006), “Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia.” Proc Natl Acad Sci U S A 103(42):15651-6 Details


Broome MR, Woolley JB, Tabraham P, Johns LC, Bramon E, Murray GK, Pariante C, McGuire PK, Murray RM (2005), “What causes the onset of psychosis?” Schizophr Res 79(1):23-34 Details

Isohanni M, Lauronen E, Moilanen K, Isohanni I, Kemppainen L, Koponen H, Miettunen J, Mäki P, Räsänen S, Veijola J, Tienari P, Wahlberg KE, Murray GK (2005), “Predictors of schizophrenia: evidence from the Northern Finland 1966 Birth Cohort and other sources.” Br J Psychiatry Suppl 48:s4-7 Details

Leeson VC, McKenna PJ, Murray G, Kondel TK, Laws KR (2005), “What happens to semantic memory when formal thought disorder remits? Revisiting a case study.” Cognit Neuropsychiatry 10(1):57-71 Details

Mäki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, Miettunen J, Tanskanen P, Wahlberg KE, Koskinen J, Lauronen E, Isohanni M (2005), “Predictors of schizophrenia--a review.” Br Med Bull 73-74:1-15 Details

Taanila A, Murray GK, Jokelainen J, Isohanni M, Rantakallio P (2005), “Infant developmental milestones: a 31-year follow-up.” Dev Med Child Neurol 47(9):581-6 Details


Isohanni M, Isohanni I, Koponen H, Koskinen J, Laine P, Lauronen E, Miettunen J, Mäki P, Riala K, Räsänen S, Saari K, Tienari P, Veijola J, Murray G (2004), “Developmental precursors of psychosis.” Curr Psychiatry Rep 6(3):168-75 Details

Isohanni M, Murray GK, Jokelainen J, Croudace T, Jones PB (2004), “The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort.” Schizophr Res 71(2-3):213-25 Details

Murray GK, Leeson V, McKenna PJ (2004), “Spontaneous improvement in severe, chronic schizophrenia and its neuropsychological correlates.” Br J Psychiatry 184:357-8 Details


Murray GK, Nandhra H, Hymas N, Hunt N (2003), “Copying letters to patients. Psychiatrists omit information from letters when they know patients will be sent copies.” BMJ 326(7386):449 Details


Takei N, Murray G, O'Callaghan E, Sham PC, Glover G, Murray RM (1995), “Prenatal exposure to influenza epidemics and risk of mental retardation.” Eur Arch Psychiatry Clin Neurosci 245(4-5):255-9 Details


O'Callaghan E, Sham PC, Takei N, Murray G, Glover G, Hare EH, Murray RM (1994), “The relationship of schizophrenic births to 16 infectious diseases.” Br J Psychiatry 165(3):353-6 Details

Takei N, Sham P, O'Callaghan E, Murray GK, Glover G, Murray RM (1994), “Prenatal exposure to influenza and the development of schizophrenia: is the effect confined to females?” Am J Psychiatry 151(1):117-9 Details


Sham PC, O'Callaghan E, Takei N, Murray GK, Hare EH, Murray RM (1992), “Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960.” Br J Psychiatry 160:461-6 Details